ArticleFrontiers in oncology2023

Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial.

Marco Maria Germani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.